中金 • 联合研究 | 多部门共同助力商业健康险发展开启新时代

Core Viewpoint - The article discusses the collaborative efforts of four major industry associations in China to address the systemic challenges faced by the commercial health insurance sector, aiming to initiate a new era of development in the industry [3][4][7]. Group 1: Policy Initiatives - The China Insurance Industry Association is leading the development of standard clauses for commercial health insurance and payment lists for innovative drugs, aiming to standardize product design and enhance supply [4][9]. - The China Actuarial Society is focused on establishing a net cost table for commercial health insurance and analyzing the costs of innovative drugs to improve pricing accuracy and risk management [4][10]. - The China Banking and Insurance Regulatory Commission is promoting the integration of health insurance data and upgrading infrastructure to eliminate data silos and enhance operational efficiency [4][10]. - The China Banking and Insurance Asset Management Association is encouraging long-term capital investment in the healthcare sector to support sustainable industry growth [4][10]. Group 2: Industry Challenges - The commercial health insurance industry has been hindered by various interrelated factors, including a lack of awareness among consumers, weak collaboration between insurers and healthcare providers, and insufficient data sharing mechanisms [8][9]. - The reliance on the medical insurance directory has limited the expansion of commercial health insurance, particularly for non-standard populations and services outside the directory [8][9]. Group 3: Investment Opportunities - The article suggests focusing on investment opportunities in four key areas: leading internet platforms and large insurance groups capable of building systematic payment solutions; brokerage channels in the corporate group insurance sector; reinsurance companies and insurers enhancing their health insurance capabilities; and pharmaceutical companies benefiting from increased commercial insurance payments [4][11].